UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

European journal of cancer (1990), 2012-06, Vol.48 (9), p.1283-1292

2012

Volltextzugriff (PDF)

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study

British journal of cancer, 2009-08, Vol.101 (4), p.621-627

2009

Volltextzugriff (PDF)

Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

Journal of clinical oncology, 2002-04, Vol.20 (8), p.1996-2004

2002

Volltextzugriff (PDF)

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

British journal of cancer, 2003-07, Vol.89 (2), p.252-257

2003

Volltextzugriff (PDF)

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

Annals of oncology, 2005-04, Vol.16 (4), p.549-557

2005

Volltextzugriff (PDF)

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

British journal of cancer, 2002-03, Vol.86 (5), p.680-685

2002

Volltextzugriff (PDF)

Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer

British journal of cancer, 2003-06, Vol.88 (12), p.1859-1865

2003

Volltextzugriff (PDF)

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG NCEPOD findings

British journal of cancer, 2011-02, Vol.104 (3), p.407-412

2011

Volltextzugriff (PDF)

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

British journal of cancer, 2012-07, Vol.107 (3), p.435-441

2012

Volltextzugriff (PDF)

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

The New England journal of medicine, 2010-04, Vol.362 (14), p.1273-1281

2010

Volltextzugriff (PDF)

13- cis -Retinoic Acid in Combination with Gemcitabine in the Treatment of Locally Advanced and Metastatic Pancreatic Cancer — Report of a Pilot Phase II Study

Clinical oncology (Royal College of Radiologists (Great Britain)), 2007-03, Vol.19 (2), p.150-153

2007

Volltextzugriff (PDF)

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

JAMA : the journal of the American Medical Association, 2012-07, Vol.308 (2), p.147

2012

Volltextzugriff (PDF)

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2010-09, Vol.304 (10), p.1073

2010

Volltextzugriff (PDF)

OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

Thrombosis research, 2010, Vol.125, p.S161-S161

2010

Volltextzugriff (PDF)

A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma

Annals of oncology, 2001-10, Vol.12 (10), p.1407-1410

2001

Volltextzugriff (PDF)

Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?

British journal of cancer, 1998-01, Vol.77 (2), p.325-328

1998

Volltextzugriff (PDF)

Phase I Study of ONO-4007, a Synthetic Analogue of the Lipid A Moiety of Bacterial Lipopolysaccharide

Clinical cancer research, 2000-02, Vol.6 (2), p.397-405

2000

Volltextzugriff (PDF)

Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam)

Annals of oncology, 1999-11, Vol.10 (11), p.1389-1392

1999

Volltextzugriff (PDF)

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

Gynecologic oncology, 2006-11, Vol.103 (2), p.439-445

2006

Volltextzugriff (PDF)

A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer

British journal of cancer, 1996-05, Vol.73 (10), p.1260-1264

1996

Volltextzugriff (PDF)

PO-56 Chemoanticoagulation versus chemotherapy in advanced pancreatic cancer (APC): results of the interim analysis of the FRAGEM trial

Thrombosis research, 2007, Vol.120, p.S163-S163

2007

Volltextzugriff (PDF)

Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo

Oncogene, 1993-10, Vol.8 (10), p.2813-2820

1993

Volltextzugriff (PDF)

Fungal empyema thoracis complicating treatment of oesophageal carcinoma

Postgraduate medical journal, 2004-03, Vol.80 (941), p.154-154

2004

Volltextzugriff (PDF)

6503 Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

European journal of cancer supplements, 2009, Vol.7 (2), p.362-362

2009

Volltextzugriff (PDF)

4184 Oral Chemotherapy: a collaborative project between acute hospital and community services

European journal of cancer supplements, 2009, Vol.7 (2), p.238-238

2009

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(107)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(56)
Humans
(48)
Female
(37)
Biological And Medical Sciences
(36)
Male
(31)
Middle Aged
(30)
Oncology
(29)
Medical Sciences
(28)
Adult
(27)
Aged
(26)
Chemotherapy
(19)
Pharmacology. Drug Treatments
(18)
Animals
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Antineoplastic Agents
(12)
Survival Analysis
(12)
Tumors
(12)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(11)
Fluorouracil - Administration & Dosage
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study

Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer

A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG NCEPOD findings

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

13- cis -Retinoic Acid in Combination with Gemcitabine in the Treatment of Locally Advanced and Metastatic Pancreatic Cancer — Report of a Pilot Phase II Study

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma

Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?

Phase I Study of ONO-4007, a Synthetic Analogue of the Lipid A Moiety of Bacterial Lipopolysaccharide

Management of adenocarcinoma of unknown primary with a 5-fluorouracil-cisplatin chemotherapy regimen (CFTam)

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer

PO-56 Chemoanticoagulation versus chemotherapy in advanced pancreatic cancer (APC): results of the interim analysis of the FRAGEM trial

Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo

Fungal empyema thoracis complicating treatment of oesophageal carcinoma

6503 Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)

4184 Oral Chemotherapy: a collaborative project between acute hospital and community services

Suchergebnisse filtern